Embolia Cutis Medicamentosa after Subcutaneous Injection with Glatiramer Acetate
Open Access
- 1 January 2021
- journal article
- research article
- Published by S. Karger AG in Case Reports in Dermatology
- Vol. 13 (1), 114-120
- https://doi.org/10.1159/000510017
Abstract
Embolia cutis medicamentosa (ECM) is a rare and unpredictable injection site reaction, occurring after intramuscular, subcutaneous, and even after intraarticular injection of various drugs. We report a very rare case of necrotizing ECM after injection of glatiramer acetate for multiple sclerosis, include a photo documentation over the entire disease course, and discuss hypotheses as to etiology and treatment.This publication has 15 references indexed in Scilit:
- GLACIER: An open-label, randomized, multicenter study to assess the safety and tolerability of glatiramer acetate 40mg three-times weekly versus 20mg daily in patients with relapsing-remitting multiple sclerosisMultiple Sclerosis and Related Disorders, 2015
- Three times weekly glatiramer acetate in relapsing–remitting multiple sclerosisAnnals of Neurology, 2013
- Significance of Ultrasound Examination of Skin and Subcutaneous Tissue in Secondary Lower Extremity LymphedemaAnnals of Vascular Diseases, 2013
- Nicolau Syndrome after Intramuscular Injection: 3 CasesArchives of Plastic Surgery, 2012
- Embolia Cutis Medicamentosa (Nicolau Syndrome) After Glatiramer Acetate InjectionActas Dermo-Sifiliográficas (English Edition), 2011
- Embolia cutis medicamentosa (síndrome de Nicolau) tras inyección de acetato de glatirámeroActas Dermo-Sifiliograficas, 2011
- Nicolau syndrome following subcutaneous glatiramer-acetate injectionJournal of the American Academy of Dermatology, 2011
- Embolia cutis medicamentosa following subcutaneous injection of glatiramer acetateJDDG: Journal der Deutschen Dermatologischen Gesellschaft, 2007
- Nicolau Syndrome: three cases and reviewInternational Journal of Dermatology, 2006
- Lokales embolisches Bismogenol-ExanthemArchiv für dermatologische Forschung, 1924